PIM
IDXX icon

Platinum Investment Management’s Idexx Laboratories IDXX Stock Holding History

Platinum Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Sell
2,900
-100
-3% -$56.1K 0.38% 70
2026
Q1 		$1.69M Hold
3,000
– – 0.42% 68
2025
Q4 		$2.03M Sell
3,000
-500
-14% -$341K 0.47% 64
2025
Q3 		$2.24M Hold
3,500
– – 0.14% 62
2025
Q2 		$1.88M Buy
+3,500
New +$1.67M 0.12% 57

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Platinum Investment Management's IDXX Position: Q2 2026 in Review

Platinum Investment Management reduced its Idexx Laboratories (IDXX) stake by 3.3% in Q2 2026, selling an estimated $56.1K and leaving 2,900 shares worth $1.53M. The position accounts for 0.38% of the portfolio, ranked #70.

Platinum Investment Management first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.24M in Q3 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Platinum Investment Management held 2,900 shares of Idexx Laboratories worth $1.53M as of Q2 2026.
  • Platinum Investment Management sold 100 Idexx Laboratories shares in Q2 2026, an estimated $56.1K.
  • Idexx Laboratories made up 0.38% of Platinum Investment Management's portfolio in Q2 2026, its #70 holding.
  • Platinum Investment Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Platinum Investment Management's Idexx Laboratories position peaked at $2.24M in Q3 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Platinum Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.